Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

Related Citations for PubMed (Select 23815928)

1.

[Treatment of leukemia with immunized donor cell infusion after nonmyeloablative haploidentical bone marrow transplantation].

Xu PF, Duan LN, Luo Y, Wang Z, Lu CR, Xiang PD, Lei YY.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Jun;21(3):711-5. doi: 10.7534/j.issn.1009-2137.2013.03.035. Chinese.

PMID:
23815928
2.
3.
4.

[The action of donor-derived NK cell in leukemic mice MHC haplotype-mismatched bone marrow transplantation].

Wang CY, Tan H, Guo KY.

Zhonghua Xue Ye Xue Za Zhi. 2009 Feb;30(2):107-10. Chinese.

PMID:
19563021
5.

[Study on nonmyeloablative allogeneic bone marrow transplantation in the treatment of L615 leukemia mice].

Xu KL, Ju JP, Pan XY, Du B, Li ZY, Lu QX.

Zhonghua Xue Ye Xue Za Zhi. 2003 Jul;24(7):372-5. Chinese.

PMID:
12941194
6.

[Experimental study on NK cells promoting donor marrow engraftment and hematopoietic reconstitution after MHC haploidentical BMT in mice].

Wang CY, Guo KY, Wu BY, Wu LX, Jiang ZY, Pan XH.

Zhonghua Xue Ye Xue Za Zhi. 2004 May;25(5):290-2. Chinese.

PMID:
15182539
7.

Effectiveness of allogeneic NK cells in haploidentical bone marrow transplantation for leukemic mice.

Wang CY, Tan H, Guo KY.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Aug;17(4):1005-9.

PMID:
19698248
8.
9.

Nonmyeloablative allogeneic bone marrow transplantation as immunotherapy for hematologic malignancies and metastatic solid tumors in preclinical models.

Prigozhina TB, Gurevitch O, Morecki S, Yakovlev E, Elkin G, Slavin S.

Exp Hematol. 2002 Jan;30(1):89-96.

PMID:
11823042
10.

The contribution of cytotoxic and noncytotoxic function by donor T-cells that support engraftment after allogeneic bone marrow transplantation.

Jiang Z, Adams GB, Hanash AM, Scadden DT, Levy RB.

Biol Blood Marrow Transplant. 2002;8(11):588-96.

PMID:
12463477
11.

Combination of intra-bone marrow-bone marrow transplantation and subcutaneous donor splenocyte injection diminishes risk of graft-versus-host disease and enhances survival rate.

Shi M, Adachi Y, Cui Y, Li M, Lian Z, Zhang Y, Yanai S, Shima C, Imai Y, Ikehara S.

Stem Cells Dev. 2011 May;20(5):759-68. doi: 10.1089/scd.2010.0232. Epub 2010 Dec 22.

12.

Anti-NK cell treatment induces stable mixed chimerism in MHC-mismatched, T cell-depleted, nonmyeloablative bone marrow transplantation.

Cho SG, Shuto Y, Soda Y, Nakazaki Y, Izawa K, Uchimaru K, Takahashi S, Tani K, Tojo A, Asano S.

Exp Hematol. 2004 Dec;32(12):1246-54.

PMID:
15588949
13.
14.

[Establishment of nonmyeloablative allogeneic stem cell transplantation model in H-2 haploidentical mice and its related study].

Li JJ, Zhang Y, Zhang MW, Hou CM, Wu Y, Mao N, Ai HS.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2004 Oct;12(5):655-60. Chinese.

PMID:
15498129
15.
16.

[Effects of sensitized donor lymphocyte infusion on the chimerism and graft-versus-host disease after nonmyeloablative allogeneic stem cell transplantation].

Chen BA, Zhang Y, Ding JH, Bi YZ, Zhao G, Gao C, Sun YY, Sun XM, Wang J, Chen NN, Cheng J.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006 Feb;14(1):102-6. Chinese.

PMID:
16584602
19.

Bone marrow transplantation combined with mesenchymal stem cells induces immune tolerance without cytotoxic conditioning.

Wang Y, Liu J, Xu C, Zhang W, Bai L, Li N, Liu Y, Wang Y, Su Y, Hu D.

J Surg Res. 2011 Nov;171(1):e123-31. doi: 10.1016/j.jss.2011.06.020. Epub 2011 Jul 13.

PMID:
21920556
20.

Robust tolerance to fully allogeneic islet transplants achieved by chimerism with minimal conditioning.

Luo B, Nanji SA, Schur CD, Pawlick RL, Anderson CC, Shapiro AM.

Transplantation. 2005 Aug 15;80(3):370-7.

PMID:
16082333
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk